Earnings calendar/ACRS
Aclaris Therapeutics, Inc. (ACRS)
Pre-earnings consensus targets and post-earnings beat/miss — standardized metrics from the earnings calendar. No narrative, no price targets.
Pre-earnings
Consensus targets for the next print, plus how the business has been running.
Next report
Nov 5, 2026
Consensus estimate row
EPS target
$-0.17
Street estimate
Revenue target
$1.3M
Street estimate
Trailing EPS (avg 4Q)
$-0.14
Beat rate last 4: 75%
Latest EPS YoY
-15.4%
vs 2025-08-07
Latest revenue YoY
-8.3%
How results look so far
Trailing revenue (avg 4Q)
$2.1M
Printed quarters
EPS beat rate (4Q)
75%
Share of quarters that beat EPS est.
Post-earnings
Did the company hit the target? Actual vs estimate and surprise.
Last print
Aug 6, 2026
EPS beat
EPS actual / est
$-0.15 / $-0.16
+6.3%
Revenue actual / est
$1.6M / $1.4M
+17.8%
Result
Target reached
Based on EPS vs consensus
Earnings history
Estimate vs actual and surprise % by print date
| Date | EPS est | EPS act | EPS surprise | Rev est | Rev act | Rev surprise |
|---|---|---|---|---|---|---|
| 11/5/2026upcoming | $-0.17 | Pending | — | $1.3M | Pending | — |
| 8/6/2026 | $-0.16 | $-0.15 | +6.3% | $1.4M | $1.6M | +17.8% |
| 5/14/2026upcoming | $-0.16 | Pending | — | $1.3M | Pending | — |
| 5/7/2026 | $-0.16 | $-0.15 | +6.3% | $1.3M | $2.0M | +51.0% |
| 2/26/2026 | $-0.15 | $-0.16 | -6.7% | $2.1M | $1.3M | -37.5% |
| 11/6/2025 | $-0.13 | $-0.12 | +7.7% | $2.1M | $3.3M | +59.3% |
| 8/7/2025 | $-0.13 | $-0.13 | 0.0% | $1.1M | $1.8M | +56.2% |
| 5/8/2025 | $-0.17 | $-0.12 | +29.4% | $3.5M | $1.5M | -59.0% |
| 2/27/2025 | $-0.32 | $-1.01 | -215.6% | $2.1M | $9.2M | +337.1% |
| 11/6/2024 | $-0.08 | $-0.11 | -37.5% | $2.1M | $4.3M | +105.0% |
| 8/7/2024 | $-0.19 | $-0.15 | +21.1% | $1.8M | $2.8M | +52.0% |
| 5/7/2024 | $-0.28 | $-0.24 | +14.3% | $1.4M | $2.4M | +75.0% |
| 2/27/2024 | $-0.37 | $-0.02 | +94.6% | $4.7M | $17.6M | +277.3% |
| 11/6/2023 | $-0.48 | $-0.41 | +14.6% | $1.6M | $9.3M | +491.2% |
| 8/7/2023 | $-0.45 | $-0.42 | +6.7% | $1.9M | $1.9M | -1.6% |
| 5/8/2023 | $-0.44 | $-0.42 | +4.5% | $1.8M | $2.5M | +44.5% |
| 2/23/2023 | $-0.46 | $-0.41 | +10.9% | $2.0M | $7.8M | +288.8% |
| 11/8/2022 | $-0.39 | $-0.30 | +23.1% | $1.6M | $19.0M | +1088.0% |
| 8/3/2022 | $-0.36 | $-0.31 | +13.9% | $1.6M | $1.5M | -5.2% |
| 5/10/2022 | $-0.39 | $-0.31 | +20.5% | $1.6M | $1.5M | -9.1% |
| 2/24/2022 | $-0.36 | $-0.37 | -2.8% | $1.8M | $1.5M | -16.2% |
| 11/2/2021 | $-0.27 | $-0.35 | -29.6% | $1.8M | $1.7M | -6.3% |
| 8/5/2021 | $-0.26 | $-0.34 | -30.8% | $1.8M | $1.8M | +4.2% |
| 5/7/2021 | $-0.27 | $-0.57 | -111.1% | $1.7M | $1.8M | +2.9% |
| 2/25/2021 | $-0.28 | $-0.31 | -10.7% | $1.4M | $1.6M | +12.5% |
| 11/4/2020 | $-0.29 | $-0.25 | +13.8% | $1.7M | $1.4M | -14.3% |
| 8/7/2020 | $-0.34 | $-0.28 | +17.6% | $2.6M | $2.0M | -22.2% |
| 5/7/2020 | $-0.29 | $-0.36 | -24.1% | $1.2M | $1.4M | +15.6% |
| 2/25/2020 | $-0.34 | $-0.46 | -35.3% | $949,000 | $1.1M | +15.4% |
| 11/7/2019 | $-0.54 | $-0.56 | -3.7% | $853,656.75 | $983,000 | +15.2% |
| 8/8/2019 | $-0.77 | $-0.72 | +6.5% | $556,495.87 | $5.9M | +953.9% |
| 5/8/2019 | $-0.80 | $-0.91 | -13.7% | $1.1M | $5.0M | +354.0% |
| 3/18/2019 | $-0.96 | $-0.99 | -3.1% | $1.8M | $3.7M | +107.1% |
| 11/6/2018 | $-1.25 | $-1.06 | +15.2% | $1.4M | $1.6M | +16.1% |
| 8/3/2018 | $-0.95 | $-1.01 | -6.3% | $4.0M | $3.7M | -7.3% |
| 5/8/2018 | $-0.99 | $-0.98 | +1.0% | $1.1M | $1.1M | -2.0% |
| 3/12/2018 | $-0.90 | $-0.80 | +11.1% | $1.2M | $999,000 | -18.7% |
| 11/7/2017 | $-0.86 | $-0.63 | +26.7% | $933,714.29 | $684,000 | -26.7% |
| 8/8/2017 | $-0.68 | $-0.56 | +17.6% | — | Pending | — |
| 5/9/2017 | $-0.54 | $-0.48 | +11.1% | — | Pending | — |
| 3/15/2017 | $-0.59 | $-0.49 | +16.9% | — | Pending | — |
| 11/3/2016 | $-0.68 | $-0.50 | +26.5% | — | Pending | — |
| 8/11/2016 | $-0.61 | $-0.62 | -1.6% | — | Pending | — |
| 5/11/2016 | $-0.50 | $-0.65 | -30.0% | — | Pending | — |
| 3/23/2016 | $-0.40 | $-0.28 | +30.0% | — | Pending | — |
| 11/18/2015 | $-2.84 | $-5.11 | -79.9% | — | Pending | — |
| 10/13/2015 | — | $-0.13 | — | — | Pending | — |
| 3/31/2015 | — | $-0.25 | — | — | Pending | — |
| 12/31/2014 | — | $-0.24 | — | — | Pending | — |
| 9/30/2014 | — | $-0.25 | — | — | Pending | — |
| 6/30/2014 | — | $-1.25 | — | — | Pending | — |
| 3/31/2014 | — | $-1.25 | — | — | Pending | — |
Need ACRS data in your own agent or pipeline?
The earnings data on this page — report dates, consensus EPS/revenue estimates, actuals and surprise history — is also available programmatically through the EvidInvest MCP server & financial data API for Claude, Cursor, or any MCP client and HTTP pipeline.